Introduction to the Medicines and Related Substances Act, 1965 (Act 101 of 1965): Setting the scene for Complementary Medicines Regulation

Similar documents
DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004

SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS

THEME: PROMOTING GOOD PRACTICES IN DRUG POLICY DEVELOPMENT AND IMPLEMENTATION

It is hereby notified that the President has assented to the following Act which is hereby published for general information:-

The objectives of the Sri Lankan National Medicinal Drug Policy are

MEDICINES CONTROL COUNCIL

THE DRUGS AND COSMETICS RULES, 1945

Pest Control Products Act

THEME: PROMOTING GOOD PRACTICES IN DRUG POLICY DEVELOPMENT AND IMPLEMENTATION

Record keeping 3. Fees and services 4. Using, recommending, providing, or selling client-care products 4. Medication 5

Health Products and Food Branch.

Electronic Health Record Sharing System Bill. Contents. Part 1. Preliminary. 1. Short title and commencement... C Interpretation...

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

CHAPTER CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)

STANDARDS AND GUIDELINES TITLE: CIRCULATION DATE: March June 2013 REVISED: June 2013 APPROVAL DATE: July 29, 2013

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

PEST DESTROYERS ACT.

Zambia UK Health Workforce Alliance & Zambia Ministry of Health Conference

Draft guidance for registered pharmacies preparing unlicensed medicines

GUIDELINES FOR FOOD IMPORT CONTROL SYSTEMS

B I L L. No. 183 An Act to amend The Saskatchewan Employment Act and The Saskatchewan Employment Amendment Act, 2014

CONTENT OF THE AUDIT LAW

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

Draft guidance for registered pharmacies providing internet and distance sale, supply or service provision

House Study Bill Introduced

LAW ON MEDICINES. Article 1. Article 2. Article 3 Manufacturing and marketing of medical devices is the activity of public interest.

Introduction The Role of Pharmacy Within a NHS Trust Pharmacy Staff Pharmacy Facilities Pharmacy and Resources 6

REGULATION (EEC) No 2309/93

Author General Management Quality Assurance

Narcotic Treatment Programs

UK Implementation of the EU Clinical Trial Directive 2001/20/EC:

It is hereby notified that the President has assented to the following Act which is hereby published for general information:-

Paper No. CB(2)662/00-01(02)

Electricity Industry Acts (Amendment) Bill

Global Policy on Interactions with Healthcare Professionals

Professional Standards and Guidance for the Sale and Supply of Medicines

MINISTRY OF HIGHER EDUCATION UNIVERSITY OF HAIL COLLEGE OF PHARMACY

Drug Act, B.E (1967) BHUMIBOL ADULYADEJ, REX. Given on the 15th day of October B.E Being the 22nd year of the present Reign.

ENROLLED SENATE BILL No. 92

Competentes en Medicamentos

CREDIT REPORTING BILL EXPLANATORY NOTES

PEST CONTROL PRODUCTS ACT

Chemicals Regulation: A comparison of US and European Approaches. James Searles

INSTITUTE FOR SAFE MEDICATION PRACTICES CANADA

Controlled Substances Act 1984

FACT SHEET PREPARED BY THE MINISTRY OF JUSTICE ON THE DANGEROUS DRUGS (AMENDMENT) ACT 2015 OVERVIEW

QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES

Guidelines for Governments on Preventing the Illegal Sale of Internationally Controlled Substances through the Internet

AS TABLED IN THE HOUSE OF ASSEMBLY

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Proposals for the reform of the regulation of unlicensed herbal remedies in the United Kingdom made up to meet the needs of individual patients

Guide to The Notification System for Exempt Medicinal Products

PEST CONTROL PRODUCTS ACT

Act on the Supervision of Financial Institutions etc. (Financial Supervision Act)

University Degree Courses in Homeopathy examples. Second Edition December 2007

The Regulatory Framework Gene Technology Act 2000 (Cth) and the Gene Technology Bill 2001 (WA)

Health Canada s GCP Compliance Program. GCP Information Sessions November 2010

Part 3 Medical Officer (MO) Work Level Standards

STANDARDS OF PRACTICE (2013)

REGULATION. on the advertising of medicinal products. SECTION I Definitions, scope and general provisions.

Food Law and Due Diligence Defence

ONLINE PUBLIC ENGAGEMENT ON PHARMACY BILL

Competencies for the nurse practitioner scope of practice

2 Human medicines: scope of regulation

PHARMACY AND DRUG ACT

National ElectricIty (Victoria) BIll

(1 May to date) ACCREDITATION FOR CONFORMITY ASSESSMENT, CALIBRATION AND GOOD LABORATORY ACT 19 OF 2006

AGREEMENT On the Uniform Principles and Rules Governing Market Circulation of Medical Devices within the Eurasian Economic Union

VOLUME 2A Procedures for marketing authorisation CHAPTER 1 MARKETING AUTHORISATION. November 2005

FAO/WHO Regional Conference on Food Safety for the Americas and the Caribbean San José, Costa Rica, 6-9 December 2005

DEPARTMENT OF TRANSPORT

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

NATIONAL ARCHIVES AND RECORDS SERVICE OF SOUTH AFRICA ACT (ACT NO. 43 OF 1996)

DEPARTMENT OF AGRICULTURE, FORESTRY AND FISHERIES REGULATIONS RELATING TO THE PERFORMANCE OF COMPULSORY COMMUNITY SERVICE (CCS)

PRINCIPLES OF VETERINARY MEDICAL ETHICS OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (AVMA)

HOSPITAL PHARMACY PRACTICE IN THE UK AND THE RESPONSIBLE PHARMACIST REQUIREMENTS

"Act" means the National Health Act, 2003 (Act No 61of 2003);

ALLIED HEALTH PROFESSIONS ACT 63 OF 1982

Drugs of Dependence (Cannabis Use for Medical Purposes) Amendment Bill 2014

Packaging Management Law

RISK MANAGEMENT PLAN

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

The Practice of Complementary and Alternative Veterinary Medicine

BAXTER HEALTHCARE PTY LIMITED TERMS AND CONDITIONS OF SALE September 1, 2011

Pharmacovigilance and the Internet: A Call for Change

RAPID ALERT SYSTEM (RAS) IN PHARMACOVIGILANCE

Healthcare Practitioners Act No. 34/2012

Standard Interpretation and Application

DECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL

Marihuana for Medical Purposes Regulations. October 16, 2014

The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?

Regulatory Risk Analysis in the European Union, United States, and Canada

CHAPTER 227 PHARMACY ARRANGEMENT OF SECTIONS

COLORADO MEDICAL BOARD RULES AND REGULATIONS REGARDING THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES

Compulsory Drug Treatment Correctional Centre Act 2004 No 42

Solvency Assessment and Management: Pillar II Sub Committee Governance Task Group Discussion Document 81 (v 3)

Regulation 3/ (12) 30 December 2010 Dnro 4848/ /2010. Clinical trials on medicinal products for veterinary use.

NATIONAL PARTNERSHIP AGREEMENT ON E-HEALTH

Transcription:

Introduction to the Medicines and Related Substances Act, 1965 (Act 101 of 1965): Setting the scene for Complementary Medicines Regulation Prof Peter Eagles Chairperson Medicines Control Council of South Africa 1

NDoH Vision & Mission Vision A long and healthy life for all South Africans Mission To improve health status through prevention of illness and the promotion of healthy lifestyles and to consistently improve the healthcare delivery system by focusing on access, equity, efficiency, quality and sustainability 2

POLICY & LEGISLATIVE FRAMEWORK National Drug Policy access to safe, efficacious quality medicines & appropriate human resources Medicines and Related Substances Act of 1965 to provide for: - The registration of medicines and related substances for human and animal use - The establishment of the MCC - The control of medicines and scheduled substances 3

LEGISLATIVE POWERS & RESPONSIBILITIES MINISTER: Appointment of MCC, Appeal Committee, Pricing Committee and Promulgation of regulations DIRECTOR GENERAL: Release of Information, Issuing of Permits for Psychotropics & Narcotics, Licensing premises 4

PILLARS OF EFFECTIVE MEDICINE REGULATION (WHO) Existence of an Independent Medicine Regulatory Authority - MCC Separation of powers, Transparency & accountability Registration of Medicines: Quality, Efficacy, Safety. Licensing: Manufacturers, Wholesalers Control Aspects: Who may manufacture, distribute, prescribe, dispense, import, export, etc Compliance with requirements : Reporting of Adverse Reactions, Medicine recalls etc Effective law enforcement 5

PILLARS OF MEDICINE REGULATION cont Sanctions and Penalties Information that may be published Confidentiality Clause (Information for health professionals and for consumers) Control of Promotion, Advertising and Ethical Conduct Prohibitions, Exemptions and Special Approvals 6

BARRIERS TO EFFECTIVE REGULATION (WHO) Absence of policy, weak legislation and regulation Lack of political will Insufficient human resources Lack of financing Corruption Absence of transparent procedures Conflict of interest 7

Who is the MCC? Statutory body Reporting to Minister of Health No staff 24 Expert members *Pediatrician *Virology & micro *Clinical pharmacology *Veterinary clinical *Pharmaceutical chemistry *Internal medicine *Toxicology & drug safety *Public health *Agriculture *Law * Complementary medicines 8

How does MCC Work Evaluators drawn from Academia, Research Institutions, Practice settings, very few in-house Nine Expert Peer Review committees meet at least every 6 weeks GMP /GCP inspections Sub committee working groups when necessary MCC every 6-8 weeks for decision making Registrar keeps register of medicines, licences etc. Registered products on MCC website 9

Medicines Control Council & Expert Committees Medicines Control Council Chairperson Medicines Control Council Registrar of Medicines Vice Chairperson Pharmaceutical and Analytical Committee Complementary Medicines Committee Clinical Trials Committee Biological Medicines Committee Names and Scheduling Committee Clinical Committee Pharmacovigilance Committee Veterinary Clinical Committee Legal Committee 10

Obligations Public safety Public protection Transparency Accountability Timely action on safety and quality Responsiveness Risk assessment minimization of harm and maximization of benefit 11

MCC Mandate Registration of medicines based on safety efficacy and quality Approval of clinical trials Monitoring of safety Response to signals Licensing manufacturers, wholesalers and distributors Ensuring compliance Provision of information 12

Effective Medicine Regulation ELEMENTS OF EFFECTIVE REGULATION Decisions should be based on scientific evidence and facts Practicable enforcement capacity Accountability and public interest/public good Safeguard against conflict of interest Limit discretionary powers Good regulatory practices and standards Independence from public, commercial and political pressure 13

Some provisions of the Law Section 14 Prohibition of sale of medicines which are subject to registration and are not registered (extemporaneous preparations allowed) Sell means sell by wholesale or retail and includes import, offer, advertise, keep, expose, transmit, consign, convey, or deliver for sale, authorise, direct or allow a sale, or prepare or possess for purposes of sale, and barter or exchange or supply or dispose of to any person whether for a consideration or otherwise; sale & sold shall have corresponding meanings. 14

DEFINITION OF A COMPLEMENTARY MEDICINE Any substance or mixture of substances which originates from plants, minerals or animals; is used or intended to be used for, or manufactured or sold for use in assisting the innate healing power of a human being or animal to mitigate, modify, alleviate, or prevent illnesses, or the symptoms thereof or abnormal physical or mental state, and in accordance with the practice of the professions regulated under the Allied Health Professions Act, 1982 (Act No 63 of 1982) 15

Categories of medicines (Regulation 25) Category D Disciplines of CAMs CAMs intended for use in humans and animals which are, without further manipulation, ready for administration, including packaged preparations where only a vehicle is added to the effective medicine Chinese medicines Ayurveda medicines Unani Tibb medicines Homoeopathic medicines Aromatherapy medicines Western Herbal medicines 16

NEED FOR CONTROL OF CAMs Minister of Health: called for the registration of complementary medicines by amending the regulations to the Medicines Act on 15 November 2013. Thus there is a requirement for the MCC to evaluate and pronounce on the safety, quality and efficacy of these medicines 17

FLEXIBILITIES IN LAW Section 21 - MCC may authorise sale of an unregistered medicine - Authorisation in writing to a person to sell during a specified period to any specified person or institution a specified quantity, purpose of the use of such medicine Assumes treating practitioner will monitor patient closely, motivation why an unregistered medicine must be used Patient must be informed that the drug is not registered and Sign informed consent form, unused drugs to be returned to suppler for disposal, follow up reports to be supplied to MCC and supplier 18

FLEXIBILITIES cont. Section 36 -Exclusion of any drug from the operations of Act 101 -The Minister may, on the unanimous recommendation of the members present at any meeting of the council, by notice in the Gazette exclude, subject to such conditions as he may determine, any medicine from the operation of any or all the provisions of this Act and may in like manner amend or withdraw such a notice 19

FLEXIBILITIES cont. Right to appeal Section 24 provides for anybody to appeal to the minister against any decision made by the MCC and the Director General 20

PRESERVATION OF SECRECY Section 34 No person shall, except for The purpose of the exercise of his powers The performance of his functions For the purpose of legal proceedings When required to do so by any competent court Under any law With the written authority of the DG 21

PRESERVATION OF SECRECY cont. Disclose to any other person any information acquired by him in the exercise of his powers or the performance of his functions under this Act and Relating to the business or affairs of any person Or use such information for self-gain Or for the benefit of his employer 22

COMMON MISCONCEPTIONS CAMs are not medicines Natural medicines are safe MCC is insensitive to public needs MCC does not share information 23

UNPACKING MISCONCEPTIONS CAMs are medicines (Refer to definition in the Act) Natural medicines are not automatically safe Regulation of medicines is based on risk and decisions are made on scientific evidence Information on registered medicines, guidelines, processes etc. is on the website www.mccza.com 24

Conclusion Regulations and Guidelines are live documents that can be adapted as need arises Further information sessions and meetings will be held to clarify further questions 25

END MCC WEBSITE: www.mccza.com The Registrar of Medicines Private Bag X828 PRETORIA 0001 Tel: 012 395 8003 Fax: 012 395 9201 Email: mogobm@health.gov.za 26